Queen's University at Kingston
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1841-10-16
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.queensu.ca
Bupivacaine Levels in Liver Resection Patients
- Conditions
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 20
- Registration Number
- NCT03145805
- Locations
- 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada
A.Fib Emergency Department Study Atrial Fibrillation
- Conditions
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 297
- Registration Number
- NCT03127085
- Locations
- 🇨🇦
Kingston Health Sciences Centre - Kingston General Hospital Site, Kingston, Ontario, Canada
TKA Using Patient-Specific Instrumentation
- Conditions
- Interventions
- First Posted Date
- 2017-04-18
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Queen's University
- Registration Number
- NCT03117959
- Locations
- 🇨🇦
Hotel Dieu Hospital, Kingston, Ontario, Canada
Affective Attentional Bias Training In Depression
- Conditions
- Interventions
- First Posted Date
- 2017-04-11
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 40
- Registration Number
- NCT03106883
- Locations
- 🇨🇦
Queen's University, Kingston, Ontario, Canada
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
- Conditions
- Interventions
- First Posted Date
- 2017-02-17
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 301
- Registration Number
- NCT03057106
- Locations
- 🇨🇦
Regional Health Authority B, Zone 2, Saint John, New Brunswick, Canada
🇨🇦University Health Network, Toronto, Ontario, Canada
🇦🇺Coffs Habour Health Campus - NCCI, Coffs Harbour, New South Wales, Australia
A Comparison of Cognitive Training Approaches in Psychotic Disorders
- Conditions
- Interventions
- First Posted Date
- 2017-01-18
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 70
- Registration Number
- NCT03024203
- Locations
- 🇨🇦
Queen's University, Kingston, Ontario, Canada
Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2021-08-20
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 6
- Registration Number
- NCT02974803
- Locations
- 🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada
🇨🇦Odette Cancer Centre, Toronto, Ontario, Canada
Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 232
- Registration Number
- NCT02960087
- Locations
- 🇨🇦
Verspeeten Family Cancer Centre, London, Ontario, Canada
🇨🇦Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
🇨🇦Odette Cancer Centre, Toronto, Ontario, Canada
The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER
- Conditions
- Interventions
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Queen's University
- Target Recruit Count
- 326
- Registration Number
- NCT02947360
- Locations
- 🇨🇦
Queen's University, Kingston, Ontario, Canada
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Canadian Cancer Trials Group
- Target Recruit Count
- 19
- Registration Number
- NCT02905318
- Locations
- 🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
🇨🇦London Regional Cancer Program, London, Ontario, Canada